Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This pilot study aims to assess the safety and treatment effect of acute dosing with IV
Remodulin in neonates with persistent pulmonary hypertension of the newborn (PPHN).